Turkey · Delayed Price · Currency is TRY IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 2.68 billion. The enterprise value is 2.65 billion.
| Market Cap | 2.68B |
| Enterprise Value | 2.65B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 165.43M |
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | -14.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.02% |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.58 |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.12 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 37.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with zero debt.
| Current Ratio | 3.09 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.29 |
Financial Efficiency
Return on equity (ROE) is -6.26% and return on invested capital (ROIC) is -1.67%.
| Return on Equity (ROE) | -6.26% |
| Return on Assets (ROA) | -0.80% |
| Return on Invested Capital (ROIC) | -1.67% |
| Return on Capital Employed (ROCE) | -1.21% |
| Weighted Average Cost of Capital (WACC) | 10.93% |
| Revenue Per Employee | 1.32M |
| Profits Per Employee | -12.86M |
| Employee Count | 50 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IST:SURGY has paid 287.07 million in taxes.
| Income Tax | 287.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.34% in the last 52 weeks. The beta is 1.21, so IST:SURGY's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -68.34% |
| 50-Day Moving Average | 22.84 |
| 200-Day Moving Average | 52.53 |
| Relative Strength Index (RSI) | 33.69 |
| Average Volume (20 Days) | 1,296,499 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:SURGY had revenue of TRY 65.97 million and -643.20 million in losses. Loss per share was -3.85.
| Revenue | 65.97M |
| Gross Profit | 30.40M |
| Operating Income | -185.21M |
| Pretax Income | -356.13M |
| Net Income | -643.20M |
| EBITDA | -182.91M |
| EBIT | -185.21M |
| Loss Per Share | -3.85 |
Balance Sheet
The company has 3.61 million in cash and no debt, with a net cash position of 3.61 million or 0.02 per share.
| Cash & Cash Equivalents | 3.61M |
| Total Debt | n/a |
| Net Cash | 3.61M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 11.47B |
| Book Value Per Share | 68.51 |
| Working Capital | 2.32B |
Cash Flow
| Operating Cash Flow | 175.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 46.09% |
| Operating Margin | -280.75% |
| Pretax Margin | -539.85% |
| Profit Margin | n/a |
| EBITDA Margin | -277.27% |
| EBIT Margin | -280.75% |
| FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.21% |
| Shareholder Yield | 0.21% |
| Earnings Yield | -24.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |